Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Change in Inventory: 2010-2025

Historic Change in Inventory for Prestige Consumer Healthcare (PBH) over the last 16 years, with Sep 2025 value amounting to $5.8 million.

  • Prestige Consumer Healthcare's Change in Inventory rose 70.49% to $5.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year increase of 140.28%. This contributed to the annual value of $9.3 million for FY2025, which is 138.11% up from last year.
  • Latest data reveals that Prestige Consumer Healthcare reported Change in Inventory of $5.8 million as of Q3 2025, which was up 31.41% from $4.4 million recorded in Q2 2025.
  • Prestige Consumer Healthcare's Change in Inventory's 5-year high stood at $16.8 million during Q4 2022, with a 5-year trough of -$13.6 million in Q4 2023.
  • Over the past 3 years, Prestige Consumer Healthcare's median Change in Inventory value was $3.4 million (recorded in 2024), while the average stood at -$110,000.
  • Per our database at Business Quant, Prestige Consumer Healthcare's Change in Inventory tumbled by 18,300.00% in 2021 and then spiked by 1,103.41% in 2022.
  • Prestige Consumer Healthcare's Change in Inventory (Quarterly) stood at -$1.7 million in 2021, then soared by 1,103.41% to $16.8 million in 2022, then plummeted by 180.87% to -$13.6 million in 2023, then skyrocketed by 77.25% to -$3.1 million in 2024, then surged by 70.49% to $5.8 million in 2025.
  • Its Change in Inventory was $5.8 million in Q3 2025, compared to $4.4 million in Q2 2025 and -$4.1 million in Q1 2025.